Congrats to @isbscience.org's Dr. Mary Brunkow on this tremendous honor! Fred Hutch is proud to be neighbors with ISB in Seattle’s South Lake Union neighborhood —a global hub of life sciences innovation. It’s inspiring to see such transformative research happening just down the street!

New Journal for ImmunoTherapy of Cancer article: Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response jitc.bmj.com/content/13/9... #JITC #ImmunoSky

📢🔬 Join Our Team! #MC3Institute is hiring 2 paid, full-time Clinical Research Fellows! Help improve #MerkelcellCarcinoma care thru patient support, clinical trials, & research, under the mentorship of Dr. Paul Nghiem. @fredhutch.org Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship

Happy Independence Day, Nigeria!🎉We proudly highlight our recent partnership with the Federal Medical Center, Ebute Metta, Lagos, aimed at enhancing cancer care infrastructure and outcomes. See here for the power of global collaboration in service of health equity: buff.ly/uTD0ZuA#Glob...

I’ve seen firsthand how a single breakthrough can change a patient’s life. The Cancer AI Alliance is designed to bring more of those breakthroughs to more patients and make even a greater difference. Congrats to Jeff Leek, Brian Bot and all the CAIA collaborators on this remarkable accomplishment!

In a study of #MCC patients, researchers found stopping immune checkpoint inhibitor therapy is associated w/ a higher risk of disease progression — 39% at 2 years compared w/ 14% among those who continued treatment. Learn More 👉 tinyurl.com/ydnr2fck @uwdermatology.bsky.social @fredhutch.bsky.social

Read more: blog-ecog-acrin.org/ecog-acrin-n...

Congratulations to Dr. Petros Grivas on receiving the 2025 Young Investigator Award from @eaonc.bsky.social! He's recognized for a distinguished record of innovative research, outstanding clinical practice, and unwavering dedication to advancing the field of genitourinary oncology.

Congratulations to Dr. Vivian Liu, heme-onc fellow in the @stanleyleelab.bsky.social & Stirewalt labs @fredhutch.bsky.social for receiving this year's ASCO Conquer Cancer Award @conquercancer.bsky.social! Nice write up by the Fred Hutch news team: www.fredhutch.org/content/www/...

Dr. Natalie Miller presents results final results from the proof-of-concept investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory #MCC. #ASCO25 meetings.asco.org/abstracts-pr...

“Remember that all through history, there have been tyrants and murderers, and for a time, they seem invincible. But in the end, they always fall. Always.” —Mahatma Gandhi

From the Himalayas to health camps in Nepal—my daughter Angira trekked 68 miles to Annapurna Base Camp to raise cancer awareness. Then she rolled up her sleeves, volunteered @binaytara.bsky.social cancer center, Janakpur. Proud of this next-gen global health advocate. binaytara.org/news/health/...

Fred Hutch experts say former President Joe Biden's recent #prostatecancer diagnosis is not a death sentence, thanks in part to Biden's own contributions to advancing cancer research through the #CancerMoonshot. bit.ly/43hFIru

Did you know melanoma makes up 1% of skin cancers but causes 80% of deaths? Dr. Shailender Bhatia of Fred Hutch & UW stresses prevention. Learn tips on our blog: buff.ly/Jg9hrla ☀️🧴 Follow @bhatia-s-md.bsky.social for more insights! #MelanomaMonday #SkinCancerAwareness

🌏 The #GlobalOncology session at #SCHD25 featured impactful presentations. Dr. Shailender Bhatia's AFFORD-IO trial in Uganda, with insights from Dr. Vivian Oehler and Dr. Benjamin Li, shows how immunotherapy can become more globally accessible. @fredhutch.bsky.social @uwmedicine.bsky.social

A study led by Fred Hutch cancer biologist Denise Galloway, PhD, that looked at the staying power of the #HPV vaccine has found that two doses provide the same amount of immune protection as three, with no additional boosters needed. bit.ly/4lHr6do

Honored to celebrate changemakers at #SCHD25! 🎉 Dr. Dan Milner (Humanitarian Award), Dr. Mazyar Shadman (Distinguished Faculty Award), and Judy Delismon (Volunteer of the Year) for their impact in cancer care & equity. Join us Apr 26 in Seattle! @binaytara.bsky.social 🔗 binaytara.org/news/educati...

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We're grateful for their extraordinary commitment. asco.org/about-asco/a... @adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social

We don't know who needs to hear this, but #Spring is coming! The #cherryblossoms are beginning to bloom around Fred Hutch's South Lake Union campus, reminding us that sunnier days are around the corner. 🌸

Lighting over Seattle tonight #wawx #wx #seattle

Less than 1 week until the next #SITC Deep Dive webinar! We will discuss the state & future of TIL therapy, #biology of #TIL therapy, approaches to develop the next generation of TIL #therapies, & considerations when implementing TIL therapy. Register now: sitcancer.org/DeepDive

SITC’s new Melanoma CPG Addendum addresses the changing treatment landscape driven by the first approved solid tumor cell therapy, lifileucel, and practice-changing guidance from the NADINA trial. Learn more here: ow.ly/5G0w50VlqHK #SITCGuidelines #Melanoma #Immunotherapy @jasonlukemd.bsky.social

Fred Hutch/@uwmedicine.bsky.social's Dan Lin, Bruce Montgomery and Ruben Raychaudhuri recently published an overview of #prostatecancer (PC) in @jama.com. PC is the most common non-skin cancer in men in the U.S. with ~300K new cases and 35K deaths in 2024. pubmed.ncbi.nlm.nih.gov/40063046/ 1/12

“Most people who have received two doses of the #MMR vaccine do not need a measles booster shot, but some specific individuals may benefit,” says Deborah Fuller, a @uwmedicine.bsky.social microbiologist. @everydayhealth.bsky.social #vaccine bit.ly/4bHMiv8

Happening now- (CME, ACPE, CNE) live webinar: "Innovations in Immune Checkpoint Inhibitor Delivery" with Dr. Petros Grivas and @bhatia-s-md.bsky.social of @fredhutch.bsky.social education.binayfoundation.org/Vitual-Optim...

And now Seattle #measles publichealthinsider.com/2025/02/27/f...

New Journal for ImmunoTherapy of Cancer ( #JITC ) short report: Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors bit.ly/43bFMuy @jasonlukemd.bsky.social @news.upmc.com @djpinato.bsky.social #OncSky #CanSky #research

🌍 On International Childhood Cancer Day (#ICCD), we spotlight the global disparity in childhood cancer survival rates, highlighting healthcare inequities. Join us at #SCHD25 to address these challenges and reduce disparities! Register now: buff.ly/3Waa3FO #ICCD2025 #ChildhoodCancer #GlobalHealth

I think people both within science and outside science don’t fully appreciate the miracle that were the Covid-19 vaccines. How much courage it took to get the sequence out, how much work had already gone into figuring out the best viral antigen and how best to present it. 1/

Just wrapped up an incredible @binaytara.bsky.social GI Oncology Summit in Honolulu! Thanks to Dr. Teruo Yamauchi for his keynote on cancer care access and Dr. David Zhen of @fredhutch.bsky.social for his leadership. #CancerCare #GIONcology #Hawaii

NIH support enables @fredhutch.bsky.social to translate research from our labs into care at patient bedsides and ensures we can continue to provide world-class therapies to 40,000+ patients each year. Thank you @repdelbene.bsky.social for championing federal biomedical research funding in Congress.

Stay informed on the latest research in cancer immunotherapy with the Feb. issue of the #JITC Digest! Check out two complete special series: "Cancer Immunotherapy in Understudied Populations" and "Computational I-O". Don’t miss these highlights and more: ow.ly/UX9V50V2WLJ #research #cancer

Thank you, @repdelbene.bsky.social, for your support of NIH funding in Congress! We were grateful to have you at Fred Hutch to tour our research facilities and discuss how vital federal biomedical research funding is in turning lab discoveries into life-saving cures.

NOW AVAILABLE: SITC Fellowships totaling $300,000 in funding! SITC is calling early career investigators looking for potential funding opportunities to apply with a Letter of Intent. Learn more about the application process here: sitcancer.org/fellowships #SITCFellowship #IO #grant #funding

Looking forward to it! And also happy that my first post on this forum is related to your Foundation with its noble mission!